Raising prices at a rate that’s more than four times greater than inflation doesn’t typically qualify as good financial stewardship. In the world of prescription drugs, however, there is a different set of rules.
If you buy a car, there is a range of reasonable price increases the market will accept. If the car company gets out of line, consumers vote with their dollars and will quickly navigate to another vehicle, without any major consequences.
The discussion about drug prices in the United States has never been so hotly debated. It has sparked interest and concern from every angle — individual consumers, employers and health plans—no one is immune from the financial pain.
Share your email and once a month we’ll send you industry news and insights.